Display options
Cite
Bhuyan SS, Chandak A, Gupta N, et al. Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey. Am J Mens Health. 2016;11(1):134-146doi: 10.1177/1557988315614082.
Bhuyan, S. S., Chandak, A., Gupta, N., Isharwal, S., LaGrange, C., Mahmood, A., & Gentry, D. (2017). Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey. American journal of men's health, 11(1), 134-146. https://doi.org/10.1177/1557988315614082
Bhuyan, Soumitra S, et al. "Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey." American journal of men's health vol. 11,1 (2017): 134-146. doi: https://doi.org/10.1177/1557988315614082
Bhuyan SS, Chandak A, Gupta N, Isharwal S, LaGrange C, Mahmood A, Gentry D. Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey. Am J Mens Health. 2017 Jan;11(1):134-146. doi: 10.1177/1557988315614082. Epub 2016 Jul 07. PMID: 26614441; PMCID: PMC5675184.
Copy Download .nbib Format: NLM
Share it on

Am J Mens Health. 2017 Jan;11(1):134-146. doi: 10.1177/1557988315614082. Epub 2016 Jul 07.

Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.

American journal of men's health

Soumitra S Bhuyan, Aastha Chandak, Niodita Gupta, Sudhir Isharwal, Chad LaGrange, Asos Mahmood, Dan Gentry

Affiliations

  1. 1 The University of Memphis, Memphis, TN, USA.
  2. 2 University of Nebraska Medical Center, Omaha, NE, USA.

PMID: 26614441 PMCID: PMC5675184 DOI: 10.1177/1557988315614082

Abstract

The American Urological Association, American Cancer Society, and American College of Physicians recommend that patients and providers make a shared decision with respect to prostate-specific antigen (PSA) testing for prostate cancer (PCa). The goal of this study is to determine the extent of patient-provider communication for PSA testing and treatment of PCa and to examine the patient specific factors associated with this communication. Using recent data from the Health Information National Trends Survey, this study examined the association of patient characteristics with four domains of patient-provider communication regarding PSA test and PCa treatment: (1) expert opinion of PSA test, (2) accuracy of PSA test, (3) side effects of PCa treatment, and (4) treatment need of PCa. The current results suggested low level of communication for PSA testing and treatment of PCa across four domains. Less than 10% of the respondents report having communication about all four domains. Patient characteristics like recent medical check-up, regular healthcare provider, global health status, age group, marital status, race, annual household income, and already having undergone a PSA test are associated with patient-provider communication. There are few discussions about PSA testing and PCa treatment options between healthcare providers and their patients, which limits the shared decision-making process for PCa screening and treatment as recommended by the current best practice guidelines. This study helps identify implications for changes in physician practice to adhere with the PSA screening guidelines.

Keywords: Prostate-specific antigen (PSA) testing; general health and wellness; health communication; healthcare issues; prostate cancer

References

  1. CA Cancer J Clin. 2009 Jan-Feb;59(1):27-41 - PubMed
  2. Cancer. 2009 Nov 1;115(21):5048-59 - PubMed
  3. Prev Med. 2001 Dec;33(6):646-52 - PubMed
  4. Am J Clin Pathol. 2014 Jul;142(1):7-15 - PubMed
  5. Am J Prev Med. 2006 May;30(5):394-404 - PubMed
  6. Am J Mens Health. 2013 Nov;7(6):461-71 - PubMed
  7. J Gen Intern Med. 2007 Jul;22(7):901-7 - PubMed
  8. Int J Cancer. 2014 Aug 15;135(4):939-47 - PubMed
  9. Ann Fam Med. 2013 Jan-Feb;11(1):67-74 - PubMed
  10. Urology. 2002 Feb;59(2):251-5 - PubMed
  11. Ann Intern Med. 2012 Jul 17;157(2):120-34 - PubMed
  12. J Urol. 2013 Aug;190(2):419-26 - PubMed
  13. JAMA. 2003 Mar 19;289(11):1414-20 - PubMed
  14. Patient Educ Couns. 2007 Feb;65(2):189-96 - PubMed
  15. J Gerontol A Biol Sci Med Sci. 1998 May;53(3):M195-200 - PubMed
  16. Ann Fam Med. 2013 Jul-Aug;11(4):315-23 - PubMed
  17. J Am Assoc Nurse Pract. 2014 Oct;26(10):574-81 - PubMed
  18. Cancer. 1999 Mar 15;85(6):1305-12 - PubMed
  19. BJU Int. 2002 Jul;90(2):162-73 - PubMed
  20. JAMA Intern Med. 2013 May 27;173(10):866-73 - PubMed
  21. J Gen Intern Med. 1996 Jun;11(6):342-9 - PubMed
  22. Ann Fam Med. 2013 Jul-Aug;11(4):306-14 - PubMed
  23. J Gen Intern Med. 2003 May;18(5):350-6 - PubMed
  24. Curr Oncol Rep. 2011 Feb;13(1):57-62 - PubMed
  25. Med Care. 1999 Jun;37(6):547-55 - PubMed
  26. Ann Intern Med. 2013 May 21;158(10 ):761-769 - PubMed
  27. Arch Intern Med. 2009 Sep 28;169(17):1611-8 - PubMed
  28. N Engl J Med. 1995 Nov 23;333(21):1401-5 - PubMed
  29. Prev Med. 2005 Apr;40(4):461-8 - PubMed
  30. J Gen Intern Med. 2007 Jul;22(7):1056-7 - PubMed
  31. BMJ. 2011 Mar 31;342:d1539 - PubMed
  32. BJU Int. 2013 Mar;111(3):389-95 - PubMed
  33. J Natl Cancer Inst. 2012 Jan 18;104(2):125-32 - PubMed
  34. Am J Public Health. 2000 Oct;90(10):1595-600 - PubMed
  35. J Prim Care Community Health. 2013 Jan;4(1):67-74 - PubMed
  36. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29 - PubMed
  37. BJU Int. 2012 Jul;110(1):16-22 - PubMed
  38. N Engl J Med. 2009 Mar 26;360(13):1320-8 - PubMed
  39. Ann Intern Med. 2010 Oct 19;153(8):536-9 - PubMed
  40. Ann Clin Biochem. 2011 Jul;48(Pt 4):310-6 - PubMed
  41. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):627-30 - PubMed
  42. Ann Intern Med. 2008 Aug 5;149(3):192-9 - PubMed
  43. N Engl J Med. 2011 Nov 24;365(21):2013-9 - PubMed
  44. Arch Intern Med. 1996 Jun 24;156(12):1333-6 - PubMed
  45. Urology. 1999 Mar;53(3):516-22 - PubMed
  46. Can J Urol. 2011 Oct;18(5):5875-83 - PubMed
  47. J Natl Cancer Inst. 2000 Oct 4;92(19):1582-92 - PubMed
  48. CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98 - PubMed

Publication Types